Definitive Healthcare (DH) Cash from Restructuring (2024 - 2025)
Definitive Healthcare posted quarterly Cash from Restructuring of $243000.0 for Q4 2025, up 26.56% year-on-year from $192000.0 in Q4 2024, and up 51.88% on a QoQ basis from $160000.0 in Q3 2025.
Definitive Healthcare (DH) has 2 years of Cash from Restructuring data on file, last reported at $243000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Restructuring rose 26.56% year-over-year to $243000.0; the trailing twelve-month figure through Mar 2026 stood at $403000.0 (down 71.84% YoY), and the FY2025 full-year result was $595000.0, down 51.98% from the prior year.
- Cash from Restructuring for Q4 2025 stood at $243000.0, up from $160000.0 in the prior quarter.
- Across five years, Cash from Restructuring topped out at $1.0 million in Q2 2024 and bottomed at $160000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Definitive Healthcare | 102.79 Mn | -10.44 Mn | 41.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 243,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Jun 30, 2024 | 1.05 Mn |